Xcout Intel
Provention Bio, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Provention Bio, Inc. — ranked by similarity to what Provention Bio, Inc. actually does, not by market-cap band.
Subscribe to see Provention Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Provention Bio, Inc.
Provention Bio, Inc. is a clinical-stage biopharmaceutical company based in Red Bank, New Jersey, focused on advancing transformational investigational therapies for the prevention and immune-mediated disease treatment.
Provention Bio, Inc. at a glance
Provention Bio, Inc. is a company headquartered in United States. Its most recent funding round raised $28.5M in April 2017. Xcout tracks 8 named people at Provention Bio, Inc., including Colleen Proctor (CFO North America).
Provention Bio, Inc. leadership
- Colleen ProctorCFO North America
- Kimberly TutwilerHead of Vaccines, North America
- Michael HulkaGeneral Counsel North America and Head of Legal Specialty Care GBU
- Rakesh KakkarHead of Manufacturing & Supply, Vaccines, US
- Chisom ObioraNorth America People & Culture Director
- Adam GluckHead U.S. and Specialty Care Corporate Affairs
2 more named people on record for Provention Bio, Inc., with roles, board committees and tenure — see the full roster →
Provention Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $28.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Provention Bio, Inc. competitors
Ranked by semantic similarity — how close each company is to Provention Bio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Health Care
Diamyd Medical develops precision medicine therapies focused on the prevention and treatment of type 1 diabetes. The company's primary product is retogatein (rhGAD65), an investigational antigen-specific immunotherapy currently undergoing late-stage clinical trials.
Close match by what they do
Providence Therapeutics Inc. is a clinical-stage biotechnology company focused on developing mRNA-based vaccines and therapeutics. The company utilizes its proprietary technology platform to advance drug pipelines and clinical trials.
Close match by what they do
Praeventix, Inc. is an early development stage biopharmaceutical company based in Exton, Pennsylvania, focused on the discovery, research, and early clinical development of novel products.
Close match by what they do
Protalex, Inc. is a biopharmaceutical company incorporated in 2014 and based in San Antonio, Texas, focused on the development of novel immunotherapeutic drugs for autoimmune diseases.
Close match by what they do
Pandion Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Cambridge and Watertown, Massachusetts. The company focuses on developing novel therapeutics to modulate the immune system for autoimmune and inflammatory diseases.
Close match by what they do
ProThera Biologics, Inc. is a biotherapeutics company developing inter-alpha inhibitor proteins for various clinical applications, with its corporate office located in Providence, Rhode Island.
Biotech
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
Biotechnology
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Biotechnology
Evommune is a clinical-stage biopharmaceutical company headquartered in Palo Alto, California, developing new treatments for immune-mediated chronic inflammatory diseases.
Close match by what they do
DiaVacs, Inc. is a San Diego-based biotechnology company founded in 2013 that develops treatments for auto-immune diseases.
Close match by what they do
Avotres Inc. is a private biotechnology company headquartered in Cedar Knolls, New Jersey, dedicated to developing therapeutic solutions for incurable immunologically mediated disorders.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Provention Bio, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Provention Bio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →